Standard BioTools EBITDA 2010-2025 | LAB
Standard BioTools ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Standard BioTools Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-166 |
| 2023 | $-63 |
| 2022 | $-102 |
| 2021 | $-51 |
| 2020 | $-33 |
| 2019 | $-34 |
| 2018 | $-23 |
| 2017 | $-39 |
| 2016 | $-55 |
| 2015 | $-34 |
| 2014 | $-38 |
| 2013 | $-16 |
| 2012 | $-16 |
| 2011 | $-17 |
| 2010 | $-13 |
| 2009 | $-16 |
| Standard BioTools Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-30 |
| 2024-12-31 | $-30 |
| 2024-09-30 | $-30 |
| 2024-06-30 | $-49 |
| 2024-03-31 | $-58 |
| 2023-12-31 | $-18 |
| 2023-09-30 | $-17 |
| 2023-06-30 | $-14 |
| 2023-03-31 | $-13 |
| 2022-12-31 | $-19 |
| 2022-09-30 | $-25 |
| 2022-06-30 | $-35 |
| 2022-03-31 | $-23 |
| 2021-12-31 | $-7 |
| 2021-09-30 | $-16 |
| 2021-06-30 | $-13 |
| 2021-03-31 | $-15 |
| 2020-12-31 | $-13 |
| 2020-09-30 | $-1 |
| 2020-06-30 | $-9 |
| 2020-03-31 | $-10 |
| 2019-12-31 | $-5 |
| 2019-09-30 | $-10 |
| 2019-06-30 | $-11 |
| 2019-03-31 | $-8 |
| 2018-12-31 | $-4 |
| 2018-09-30 | $-5 |
| 2018-06-30 | $-6 |
| 2018-03-31 | $-7 |
| 2017-12-31 | $-4 |
| 2017-09-30 | $-11 |
| 2017-06-30 | $-12 |
| 2017-03-31 | $-13 |
| 2016-12-31 | $-13 |
| 2016-09-30 | $-14 |
| 2016-06-30 | $-14 |
| 2016-03-31 | $-15 |
| 2015-12-31 | $-10 |
| 2015-09-30 | $-4 |
| 2015-06-30 | $-10 |
| 2015-03-31 | $-10 |
| 2014-12-31 | $-6 |
| 2014-09-30 | $-9 |
| 2014-06-30 | $-9 |
| 2014-03-31 | $-14 |
| 2013-12-31 | $-4 |
| 2013-09-30 | $-4 |
| 2013-06-30 | $-3 |
| 2013-03-31 | $-4 |
| 2012-12-31 | $-3 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-4 |
| 2012-03-31 | $-6 |
| 2011-12-31 | $-2 |
| 2011-09-30 | $-4 |
| 2011-06-30 | $-6 |
| 2011-03-31 | $-5 |
| 2010-12-31 | $-2 |
| 2010-09-30 | $-3 |
| 2010-06-30 | $-4 |
| 2010-03-31 | $-5 |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.505B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.442B | 59.08 |
| Hims & Hers Health (HIMS) | United States | $14.813B | 153.91 |
| Doximity (DOCS) | United States | $11.035B | 51.09 |
| Tempus AI (TEM) | United States | $9.797B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.475B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.673B | 57.39 |
| Hinge Health (HNGE) | United States | $3.507B | 0.00 |
| Privia Health (PRVA) | United States | $2.380B | 162.67 |
| 10x Genomics (TXG) | United States | $1.656B | 0.00 |
| Phreesia (PHR) | United States | $1.604B | 0.00 |
| Enovis (ENOV) | United States | $1.531B | 8.53 |
| Azenta (AZTA) | United States | $1.497B | 69.57 |
| Schrodinger (SDGR) | United States | $1.492B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.471B | 0.00 |
| Omnicell (OMCL) | United States | $1.453B | 27.44 |
| Evolent Health (EVH) | United States | $1.180B | 100.50 |
| Claritev (CTEV) | United States | $0.655B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.523B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.423B | 0.00 |
| Talkspace (TALK) | United States | $0.407B | 121.50 |
| TruBridge (TBRG) | United States | $0.313B | 694.00 |
| Outset Medical (OM) | United States | $0.285B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.254B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.195B | 0.00 |
| CapsoVision (CV) | United States | $0.179B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.160B | 0.00 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.114B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.113B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 3.84 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.077B | 0.00 |
| Pulmonx (LUNG) | United States | $0.074B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |